Syschem (India) Ltd
₹35.12▲ +0.35 (+1.01%)
SYSCHEM·BSE·Healthcare
Market Cap
188.30 Cr
PE Ratio
14.05
Volume
6,856
Day High - Low
36.55 - 34.77
52W High-Low
59.39 - 28.81
₹35.12▲ +0.35 (+1.01%)
Market Cap188.30 Cr
PE Ratio14.05
Volume6,856
Day High - Low36.55 - 34.77
52W High-Low59.39 - 28.81
Syschem (India) Ltd (SYSCHEM): company summary
The company's business has grown significantly, with annual revenue rising 69.5% year-over-year and net profit surging 2276.1% to ₹11 crore.
Syschem (India) Ltd (SYSCHEM) is a micro-cap Healthcare company valued at ₹188 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Syschem (India) Ltd last traded at ₹35.12, modestly up 1.01% on the day.
- Recent developments
- On 2026-09-30, the promoter's holding increased by 3.23 percentage points to 63.38%, indicating a strengthening position. In the latest quarter, the company reported a net loss of ₹2 crore, reversing a profit of ₹2 crore in the same quarter a year earlier, suggesting a temporary dip in performance.
- Financial performance
- The company's business has grown significantly, with annual revenue rising 69.5% year-over-year and net profit surging 2276.1% to ₹11 crore. However, the latest quarter showed a sharp reversal, with revenue falling 0.6% compared to the same quarter a year earlier and net profit swinging from a profit of ₹2 crore to a loss of ₹2 crore.
- Valuation multiples
- The stock trades at 14.1 times earnings, a discount to the Healthcare median of 32.0, 1.15 times book value.
- Things to watch
- The company's latest quarter ended with a net loss of ₹2 crore, reversing a profit from the same quarter a year earlier. The stock is 41.5% below its 52-week high, and domestic institutional holding decreased by 0.10 percentage points in the quarter.
- Where it stands
- Syschem (India) Ltd has shown strong growth in annual revenue and net profit, but the latest quarter ended with a net loss. The promoter's holding increased, but the stock is significantly below its recent high. The most notable movement was the swing from a profit to a loss in the latest quarter.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
5.0/10
Weak
Fair Value
Sign in to see
ROE
8.93%
Average
P/E
14.05x
Cheap
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
Day₹34.77
₹36.55
52W₹28.81
₹59.39
DocStoX take
Supported by growth (8.5) and valuation (6.9), but held back by momentum (0.8). Growth looks strong at 8.5, but that is offset by momentum at 0.8 and quality at 2.5. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence5.0
/10
Weak
Quality
Weak
ROE 8.9%
Valuation
Fair
P/E 14.1×
Growth
Strong
Revenue +57.3% 5Y CAGR
Risk
Moderate
D/E 0.00
Momentum
Weak
21% of 52-week range
At a glance
Market Cap
₹188 Cr
52W High / Low
₹59 / ₹29
Dividend Yield
0.00%
Promoter Holding
63.38%
EPS (TTM)
₹2.50
Book Value
₹24.98
Key highlights
- Revenue compounding 57% a year
- Low leverage — D/E 0.00
- Profit compounding 30% a year
- Momentum is weak (0.8/10)
- Near the bottom of its 52-week range (21%)
4 Positives3 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Syschem (India) Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Syschem (India) Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedLaurus Labs LimitedZydus Lifesciences LimitedApollo Hospitals Enterprise LimitedCipla LimitedDr. Reddy's Laboratories LimitedMankind Pharma LimitedAurobindo Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Syschem (India) Ltd with peers
Syschem (India) Ltd vs Sun Pharmaceutical Industries LimitedSyschem (India) Ltd vs Divi's Laboratories LimitedSyschem (India) Ltd vs Torrent Pharmaceuticals LimitedSyschem (India) Ltd vs Laurus Labs LimitedSyschem (India) Ltd vs Zydus Lifesciences LimitedSyschem (India) Ltd vs Apollo Hospitals Enterprise Limited
Related tools & concepts
Value Syschem (India) Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing